PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

PAR Investor Meeting - Questions from HC, page-8

  1. 4 Posts.
    Can you please advise whether PAR will be announcing to the market the interim results of the 30 subjects PARA_OA_008 Synovial Fluid Biomarker Study?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.